NCI's Office of Physical Sciences-Oncology presents:
Leroy Hood, M.D., Ph.D.: Systems Approaches to Medicine and Cancer
Dr. Hood, Co-founder of the Institute for Systems Biology and inventor of the DNA sequencer, will address the application of systems approaches to cancer research, interpretation of signal versus noise, the use of single cell measurements, data integration, and the current and future states of systems biology.
Date: Tuesday, Nov. 2, 2010
Time: 4:00-5:00 p.m. ET (Please arrive by 3:45 p.m.)
Location: Natcher Conference Center (Building 45), NIH Campus, Bethesda, Md.
NCI's Office of Physical Sciences-Oncology invites you to attend this event. For questions or to register, email: nci.physics@mail.nih.gov. Registration is not required but is encouraged. The event will be VideoCast live from videocast.nih.gov.
Individuals with disabilities who need reasonable accommodation to participate in this seminar should email their requirements to nci.physics@mail.nih.gov or the call the Federal Relay at 1-800-877-8339 at least one week in advance.
Biography
Dr. Hood is recognized around the world for leading the team at Caltech in the 1980s that invented the high-speed DNA sequencing machines that made the Human Genome Project possible. In 2007, he was elected into the Inventors Hall of Fame for the automated DNA sequencer.
Dr. Hood's research has focused on the study of molecular immunology, biotechnology and genomics. Currently, he is pioneering the idea that the systems approach to disease, emerging technologies, and powerful new computational and mathematical tools will move medicine from its current reactive mode to a predictive, preventive, personalized and participatory mode (P4 medicine) over the next 5-20 years. He has published more than 700 articles in peer-reviewed journals and co-authored textbooks in biochemistry, immunology, molecular biology and genetics, and is just finishing a textbook on systems biology.
His lifelong contributions to biotechnology have earned him several prestigious awards including the Biotechnology Heritage Award, Association for Molecular Pathology Award for Excellence in Molecular Diagnostics, Lemelson-MIT Prize for Innovation and Invention, Kyoto Prize in Advanced Technology and Lasker Prize.
